Korea

J INTS BIO successfully held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR TKI (JIN-A02) in Vienna, Austria during WCLC

SEOUL, South Korea, Aug. 19, 2022 /PRNewswire/ -- J INTS BIO announced that it held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR-TKI 'JIN-A02' on the sideline of the 2022 IASLC World Conference on Lung Cancer held inVienna, Austria, on 7th August. This follo...

2022-08-19 16:00 1097

Amorepacific Develops World's First Chip-less Wireless Electronic Skin Enabled by Semiconductors

SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- Amorepacific, a South Korean beauty and cosmetics conglomerate, in collaboration with ProfessorKim Jeehwan at MIT, has developed the world's first chip-less wireless wearable electronic skin (e-skin) that is sweatproof and can continuously monitor ...

2022-08-19 02:00 1734

CG Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Ivaltinostat for the Treatment of Pancreatic Adenocarcinoma

ORINDA, Calif. and SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- CG Pharmaceuticals, Inc. announced the first patient dosed with the ivaltinostat and capecitabine combination therapy for the Phase1b/2 pancreatic adenocarcinoma (PDAC) maintenance study. Commencement of treatment for the first...

2022-08-18 21:00 1441

Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery

Veteran biotech and pharmaceutical executive will help company increase its growth and international impact SEOUL, South Korea, Aug. 18, 2022 /PRNewswire/ -- Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, toda...

2022-08-18 20:30 1793

SwatchOn Launches a Digital Twin 3D Fabric Library to Forge Fashion's Future.

Seoul, South Korea, Aug. 17, 2022 /PRNewswire/ -- Wholesale fashion fabric aggregate SwatchOn has launched its sister service,VMOD 3D Library , to fully digitize the 200,000 fabrics on SwatchOn's innovative sourcing platform...

2022-08-17 18:35 2073

RemoteMeeting Now Available on LG Smart TVs

LG webOS TV owners first to benefit from Rsupport's video-conferencing service, RemoteMeeting,on the big screen at home SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- Remote work, workcation, or hybrid work have become part of a mainstream, a paradigm shift also has begun in video conferencin...

2022-08-16 21:00 3230

STANDIGM WINS GOLD AND BRONZE STEVIE® AWARDS IN 2022 INTERNATIONAL BUSINESS AWARDS®

Winners to Be Celebrated During Event in London on 15 October SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- Standigm was named the winner of a Gold Stevie® Award in the Pharmaceutical category and a Bronze Stevie® Award in the Computer Software category in The...

2022-08-16 20:30 2711

Kakao Entertainment to hold global K-Pop auditions, starting with applications in the U.S.

SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- Representing popular K-pop artists such as Monsta X, IVE, and The Boyz, Kakao Entertainment is set to hold a series of auditions around the world to discover next-generation K-pop singers and idol groups.

2022-08-16 20:00 3886

J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' at the 2022 World Conference on Lung Cancer in Vienna, Austria (IASLC 2022 WCLC)

SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- J INTS BIO announced that the pre-clinical data of its novel, orally administered 4th generation EGFR TKI 'JIN-A02' was presented on the 8th of August, at the 2022 IASLC World Conference on Lung Cancer held inVienna, Austria, during the official s...

2022-08-16 13:35 1672

Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877

* BBT-877 is intended to explore its treatment efficacy in idiopathic pulmonary fibrosis patients in a Phase II trial expected to start in 2022 SEONGNAM, South Korea, Aug. 15, 2022 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing ...

2022-08-16 08:17 1937

Lunit Announces Financial Results for the First Half of 2022

* Consolidated revenue in the second quarter of 2022 increased by 190% compared to same prior-year period * Total revenue for H1 2022 amounted to KRW 5.48 billion, or 82.5% of the total revenue of last year SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ -- Lunit (KRX: 328130.KQ), a global pro...

2022-08-12 21:00 11908

JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform - A First for Korean Pharma.

SEOUL, South Korea, Aug. 11, 2022 /PRNewswire/ -- J INTS BIO announced that the pre-clinical data of its novel, orally administered 4th generation EGFR TKI 'JIN-A02' was presented at the 2022 IASLC World Conference on Lung Cancer in Vienna, Austria on 8th August, at the official session "Overcomin...

2022-08-12 10:13 1786

Panacell Biotech to conduct toxicity tests for NK cells, exosomes, and brown adipose-derived stem cells to treat patients with long COVID

SEOUL, South Korea, Aug. 10, 2022 /PRNewswire/ -- Panacell Biotech Co., Ltd. said that NK cells, exosomes, and brown adipose-derived stem cells are effective to treat patients with long COVID conditions, or post COVID-19 conditions, as well as those with terminal illness.

2022-08-10 22:00 2766

Bridge Biotherapeutics Presents Promising Interim Clinical Study Results from Phase 1 Study of BBT-176 at WCLC 2022

* The study confirmed preliminary efficacy and safety of BBT-176 along with its treatment responses in advanced NSCLC patients * A patient with the C797S triple mutation showed up to 53 percent reduction in EGFR mutant allelic change VIENNA and SEONGNAM, South Korea, Aug. 9, 2022 /PRNewswire/...

2022-08-10 11:43 1753

VIS BLANC participated in International Cosmetic Exhibitions in earnest

SEOUL, South Korea, Aug. 9, 2022 /PRNewswire/ -- ELKO Trading's brand 'VIS BLANC', which has been supplying famous overseas brands for 30 years, introduced a new product (2STEP MASK) that fits the brand concept through the International Cosmetics Expo held at COEX in Korea this year. VIS BLANC al...

2022-08-10 10:38 1466

iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform

* CRISPR/Cas system for bacteria that are not E. coli or Streptococcus pyogenes * Customized gene editing technology for unique modified-bacteriophages * To validate efficacy of SARS-CoV-2 mimotopes loaded PHAGERUS® platform BOSTON and SEOUL, South Korea, Aug. 9, 2022 /PRNewswire/ -- iNtRON ...

2022-08-10 09:00 1580

StradVision announces close of $88m Series C funding round

* ADAS industry leader StradVision announces the close of their $88m Series C funding round by ZF, Aptiv, and other financial investors. SEOUL, South Korea, Aug. 9, 2022 /PRNewswire/ -- StradVision , an AI-based perception processing company for Autonomous Vehicles ...

2022-08-09 23:00 2925

Bespin Global, named 'a Visionary' in 2022 Gartner® Magic Quadrant™ for Public Cloud IT Transformation Services

-       Only 20 companies in the world are named in this category, after the establishment of the new market last year,Bespin Global has been recognized as 'a Visionary' this year -       Bespin Global, recognized for its vision and execution -       Bespin Global named on Gartner® Magic Quadrant™...

2022-08-05 21:00 4997

CGBio Signing a North America Out-license Contract on "Novosis rhBMP-2," a Bone Substitute with Orthofix, USA

* Embarking on a successful journey of exporting its home-grown product technology toNorth America, the largest market for bone substitutes * Enabling fast bone formation by applying bone morphogenetic protein (rhBMP-2) and next-generation synthetic carrier SEOUL, South Korea and LEWISVILLE, ...

2022-08-04 21:00 2383

ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022

-   STP0404 is the only clinical safety proven HIV treatment candidate with a novel mechanism that can block HIV re-activation. -   STP0404 is expected to enter Phase 2a clinical trial in the US in 4Q 2022. SEOUL, South Korea, Aug. 3, 2022 /PRNewswire/ -- ST Pharm Co., Ltd. (237690:KOSDAQ) annou...

2022-08-03 20:00 1913
1 ... 60616263646566 ... 111

Week's Top Stories